Research Article
Anticancer and Antimicrobial Activity of Some New 2,3-Dihydro-1,5-benzodiazepine Derivatives
Table 3
Crystallographic data and structure refinement summary for compounds 9.
| | Property | Compound 9 |
| | Formula | C19H20N2O, CH4O | | CCDC | 2141381 | | Formula weight | 324.41 | | Crystal system | Monoclinic | | Space group | P21/c | | a (Ǻ) | 12.4123 (7) | | b (Ǻ) | 7.3789 (3) | | c (Ǻ) | 19.6257 (11) | | α (°) | 90 | | β (°) | 98.609 (2) | | γ (°) | 90 | | V (Å3) | 1777.25 (16) | | Z | 4 | | ρ (g/cm3) | 1.212 | | µ (mm−1) | 0.079 | | F (000) | 696 | | Crystal size (mm) | 0.43 × 0.50 × 0.50 | | Temperature (K) | 296 | | MoKa radiation (Ǻ) | 0.71073 | | Theta min-max (°) | 1.7, 28.3 | | Dataset | −16 : 15; −8 : 9; −22 : 26 | | Tot., uniq. data, R (int) | 31222, 4349, 0.031 | | Observed data (I > 2.0 sigma (I)) | 3532 | | Nref | 4349 | | Npar | 226 | | R | 0.0466 | | wR2 | 0.13090 | | S | 1.04 | | Max. and av. shift/error | 0.00, 0.00 | | Δρmin, Δρmax (e Å-3) | −0.33, 0.42 | | Max. resd. dens. (e/Å3) | 0.42 |
|
|
